NasdaqGM - Delayed Quote USD

ARS Pharmaceuticals, Inc. (SPRY)

Compare
14.29
-0.03
(-0.21%)
At close: January 30 at 4:00:01 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CHAKMA JUSTIN Officer Conversion of Exercise of derivative security Dec 13, 2024 136,380
DORSEY BRIAN T Chief Operating Officer Conversion of Exercise of derivative security Dec 12, 2024 6,024
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security Sale Nov 12, 2024 --
KARAS ERIC Officer Conversion of Exercise of derivative security Dec 4, 2024 5,693
LOWENTHAL RICHARD E Chief Executive Officer Sale Dec 17, 2024 --
ORBIMED ADVISORS, L.L.C. Unknown Sale Aug 26, 2024 --
SCOTT KATHLEEN D Chief Financial Officer Conversion of Exercise of derivative security Oct 16, 2024 13,199
SHAWVER LAURA Director Conversion of Exercise of derivative security Jan 6, 2025 210,346
TANIMOTO SARINA Officer and Beneficial Owner of more than 10% of a Class of Security Sale Dec 17, 2024 --
THOMPSON PETER A Director Sale Aug 26, 2024 --

Related Tickers